Phibro Animal Health (PAHC) Cash & Equivalents Growth (1y) (2014 - 2026)
Analysis
Phibro Animal Health (PAHC) Cash & Equivalents Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.51 Bn | 40.32 Bn | 779.09 Mn | 19.65% |
| 2 | Zoetis | 30.62 Bn | 28.94 Bn | 1.05 Bn | 2.86% |
| 3 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | -1.67% |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn | -9.73% |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | 47.71% |
| 6 | Zhengye Biotechnology Holding | 74.81 Mn | 67.72 Mn | - | 174.00% |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 23.27% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.73% |
| Mar 31, 2026 | -8.99% |
| Dec 31, 2025 | -17.28% |
| Sep 30, 2025 | 40.38% |
| Jun 30, 2025 | -3.65% |
| Mar 31, 2025 | 20.17% |
| Dec 31, 2024 | 103.44% |
| Sep 30, 2024 | 20.12% |
| Jun 30, 2024 | 71.05% |
| Mar 31, 2024 | 34.88% |
| Dec 31, 2023 | -51.81% |
| Sep 30, 2023 | -43.43% |
| Jun 30, 2023 | -44.40% |
| Mar 31, 2023 | -47.37% |
| Dec 31, 2022 | 7.95% |
| Sep 30, 2022 | 85.26% |
| Jun 30, 2022 | 47.87% |
| Mar 31, 2022 | 44.08% |
| Dec 31, 2021 | 83.54% |
| Sep 30, 2021 | 32.96% |